Skip to main content
Log in

Cloning of primary human tumor colony forming units in glass capillaries

  • Published:
Journal of tissue culture methods

Summary

Techniques are described for growth of primary human tumor colony-forming units in agar in glass capillary tubes. Tissue recovered from an invasive procedure is made into a single cell suspension. The cells are washed and placed in tissue culture media and agar in glass capillary tubes. After 10 to 14 d of incubation, colonies of tumor cells are visible in the capillaries. This technique can be used to determine the sensitivity pattern of patients' tumors to conventional and investigational anticancer agents. The technique can also be used to screen for antitumor activity of new chemical entities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

V. References

  1. Alberts, D. S.; Chen, H. S.; Soehnlen, B. S., et al.In vitro clonogenic assay for predicting response to ovarian cancer to chemotherapy. Lancet 2:340–342; 1980.

    Google Scholar 

  2. Ali-Osman, F.; Beltz, P. A. Optimization and characterization of the capillary human tumor clonogenic cell assay. Cancer Res. 48:715–724; 1988.

    Google Scholar 

  3. Ali-Osman, F.; Maurer, H. R.; Bier, J.In vitro cytostatic drug sensitivity testing in the human tumor stem cell assay: a modified method for the determination of the sensitivity index. Tumor Diagn. Ther. 4:1–6; 1983.

    Google Scholar 

  4. Buick, R. N.; Fry, S. E.; Salmon, S. E. Application ofin vitro soft agar technique for growth of tumor cells to the study of colon cancer. Cancer 45:1238–1242; 1980.

    Google Scholar 

  5. Buick, R. N.; Stanisic, T. H.; Fry, S. F., et al. Development of an agarmethyl cellular clonogenic assay for cells in transitional cell carcinoma of the human bladder. Cancer Res. 39:5051–5056; 1979.

    Google Scholar 

  6. Carney, D. N.; Gazdar, A. F.; Minna, J. D. Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small cell carcinoma of the lung. Stem Cells 1:149–206; 1982.

    Google Scholar 

  7. Epstein, L. B.; Shen, J. T.; Abele, J. S., et al. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by anin vitro semisolid agar technique. Ann. NY Acad. Sci. 350P:228–247; 1980.

    Google Scholar 

  8. Hamburger, A.; Salmon, S. E. Primary bioassay of human myeloma stem cells. J. Clin. Invest. 60:846–854; 1977.

    Google Scholar 

  9. Hamburger, A.; Salmon, S. E. Primary bioassay of human myeloma stem cells. Science 197:461–463; 1977.

    Google Scholar 

  10. Hamburger, A. W.; Salmon, S. E.; Kim, M. B., et al. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res. 38:3438–3444; 1978.

    Google Scholar 

  11. Hanauske, A-R.; Hanauske, U.; Buchok, J., et al. Recombinant human transforming growth factor alpha stimulatesin vitro colony formation of fresh human tumor specimens. Int. J. Cell Cloning 6:221–229; 1988.

    Google Scholar 

  12. Hutton, J. J.; Von Hoff, D. D. Cytotoxicity of 2-chlorodeoxyadenosine in a human tumor colony-forming assay. Cancer Drug Delivery 3:115–122; 1986.

    Google Scholar 

  13. Jones, S. F.; Hamburger, A. W.; Kim, M. B., et al. Development of a bioassay for putative human lymphoma stem cells. Blood 53:294–303; 1979.

    Google Scholar 

  14. Lathan, B.; Diehl, V.; Clark, G. M., et al. Cytotoxic activity of 9-β-D-arabinofuranosy1-2, fluoruadenine 5 monophosphate (Fludarabine, NSC312887) in a human tumor cloning system. Eur. J. Cancer Clin. Oncol. 24:1891–1895; 1988.

    Google Scholar 

  15. Loesch, D. M.; Von Hoff, D. D.; Page, C. P., et al. Direct cloning of human adenocarcinoma of the colon in soft agar: relationship to Duke's Stage at time of diagnosis and degree of differentiation. Stem Cells 1:313; 1982.

    Google Scholar 

  16. Mattox, D. E.; Von Hoff, D. D. Culture of human head and neck cancer stem cells using soft agar. Arch. Otolaryngol. 106:672–674; 1980.

    Google Scholar 

  17. Mattox, D. E.; Von Hoff, D. D.In vitro stem cell assay in head and neck squamous carcinoma. Am. J. Surg. 140:527–530; 1980.

    Google Scholar 

  18. Meyskens, F. L., Jr. Human melanoma colony formation in soft agar. In: Salmon. S., ed. Cloning of human tumor stem cells. NY: Alan Liss; 1980:85–99.

    Google Scholar 

  19. Meyskens, F. L., Jr.; Salmon, S. E. Inhibition of human melanoma colony formation by retinoids. Cancer Res. 39:4055–4057; 1979.

    Google Scholar 

  20. Ogawa, M.; Bergsagel, D. E.; McCulloch, E. A. Chemotherapy of mouse myeloma: quantitative cell cultures predictive of responsein vivo. Blood 41:7–15; 1973.

    Google Scholar 

  21. Ozols, R. F.; Wilson, J. K. U.; Weltz, M. D., et al. Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites. Cancer Res. 40:4109–4112; 1980.

    Google Scholar 

  22. Park, C. H.; Bergsagel, D. E.; McCulloch, E. A. Mouse myeloma tumor stem cells: a primary cell culture assay. JNCI 46:411–422; 1971.

    Google Scholar 

  23. Pavelic. Z. P.; Slocum, H. K.; Rustum, Y. M., et al. Colony growth in soft agar of human melanoma, sarcoma and lung carcinoma cells disaggregated by mechanical and enzymatic methods. Cancer Res. 40:2160–2164; 1980.

    Google Scholar 

  24. Pavelic, Z. P.; Slocum, H. K.; Rustum, Y. M., et al. Growth of cell colonies in soft agar from biopsies of different human solid tumors. Cancer Res. 40:4151–4158; 1980.

    Google Scholar 

  25. Perkins, T.; Von Hoff, D. D. Experience with a two layer soft agar system for growing gastronintestinal malignancies. In: Straelin, J. R.; Romsdahl, M. M., eds. New York: Raven Press, 1981:381–389.

    Google Scholar 

  26. Pollard, E. B.; Tio, F.; Myers, J. W. Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung. Cancer Res. 41:1015–1020; 1981.

    Google Scholar 

  27. Rosenblum, M. L.; Knebel, K. D.; Vasquez, D. A. Brain tumor therapy: quantitative analysis using a model system. J. Neurosurg. 46:145–154; 1977.

    Google Scholar 

  28. Rosenblum, M. L.; Vasquez, D. A.; Hoshine, T., et al. Development of a clonogenic cell assay for human brain tumors. Cancer 41:2305–2314; 1978.

    Google Scholar 

  29. Salmon, S. E.; Alberts, D. S.; Durie, B. G. M., et al. Clinical correlations of drug sensitivity in the human tumor stem cell assay. Recent Results Cancer Res. 74:300–305; 1980.

    Google Scholar 

  30. Salmon, S. E.; Hamburger, A. W.; Soehnle, B., et al. Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N. Engl. J. Med. 298:1323–1327; 1978.

    Google Scholar 

  31. Sarosdy, J. F.; Lamm, D. L.; Radwin, H. M., et al. Assay for clonogenic cells of human genitourinary cancer. Surg. Forum 31:583–585; 1980.

    Google Scholar 

  32. Sarosdy, M. F.; Lamm, D. L.; Radwin, H. M., et al. Clonogenic assay andin vitro chemosensitivity testing of human urologic malignancies. Cancer 50:1332–1338; 1982.

    Google Scholar 

  33. Selby, P.; Buick, R. N.; Tannock. I. A critical appraisal of the human tumor stem cell assay. N. Engl. J. Med. 308:129–134; 1983.

    Google Scholar 

  34. Shoemaker, R. H.; Wolpert-Defillipes, M. K.; Kern, D. H., et al. Application of a human tumor colony-forming assay to new drug screening. Cancer Res. 45:2145–2153; 1985.

    Google Scholar 

  35. Taylor, C. W.; Alberts, D. S.; Ketcham, M. A., et al. Clinical pharamacology of a novel diarylsulfonylurea antitumor agent. J. Clin. Oncol. 7:1733–1740; 1989.

    Google Scholar 

  36. Von Hoff, D. D. He's not going to talk aboutin vitro predictive assays again, is he? JNCI 82:46–101; 1990.

    Google Scholar 

  37. Von Hoff, D. D. Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development. Cancer Metast. Rev. 7:357–371; 1988.

    Google Scholar 

  38. Von Hoff, D. D. In vitro predictive testing: the sulfonamide era. Int. J. Cell Cloning. 5:179–190; 1987.

    Google Scholar 

  39. Von Hoff, D. D. New leads from the laboratory for treating testicular cancer. In: Van Sterem, A. T., ed. Therapeutic program in ovarian cancer, testicular cancer, and sarcomas. Boston:Martin Hijhoff; 1980:225–234.

    Google Scholar 

  40. Von Hoff, D. D. Send this patient's tumor for culture and sensitivity? N. Engl. J. Med. 308:154–155; 1983.

    Google Scholar 

  41. Von Hoff, D. D.; Casper, J.; Bradley, E., et al. Association between human tumor colony forming assay results and response of an individual patient's tumor to chemotherapy. Am. J. Med. 70:1027–1032; 1981.

    Google Scholar 

  42. Von Hoff, D. D.; Casper, J.; Bradley, E., et al. Direct cloning of human neuroblastoma cells in soft agar culture. Cancer Res. 40:3591–3597; 1980.

    Google Scholar 

  43. Von Hoff, D. D.; Clark, G. M.; Stogdill, B. J., et al. Prospective clinical trial of a human tumor cloning system. Cancer Res. 43:1926–1931; 1983.

    Google Scholar 

  44. Von Hoff, D. D.; Coltman, C. A., Jr.; Forseth, B. Activity of mitoxantrone in a human tumor cloning system. Cancer Res. 41:1853–1855; 1981.

    Google Scholar 

  45. Von Hoff, D. D.; Cowan, J.; Harris, G., et al. Human tumor cloning on feasibility and clinical correlations. Cancer Chemother. Pharmacol. 6:265–271; 1981.

    Google Scholar 

  46. Von Hoff, D. D.; Forseth, B.; Harrison, G., et al. Direct cloning of human malignant melanoma in soft agar culture. Cancer 50:84–89; 1982.

    Google Scholar 

  47. Von Hoff, D. D.; Forseth, B. J.; Huong, M., et al. Improved plating effeciencies for human tumors cloned in capillary tubes versus petri dishes. Cancer Res. 46:4012–4017; 1986.

    Google Scholar 

  48. Von Hoff, D. D.; Harris, G. J.; Johnson, G., et al. Initial experience the human tumor stem cell assay system: potential and problems. In: Salmon, S., ed. Cloning of human tumor stem cells. NY: Alan R. Liss; 1980:113–124.

    Google Scholar 

  49. Von Hoff, D. D.; Huong, A. M. Effect of recombinant beta interferon (rIFN-β 34r ) on primary human tumor colony forming units. J. Interferon Res. 8:813–820; 1988.

    Google Scholar 

  50. Von Hoff, D. D.; Sandbach, J. F.; Clark, G. M., et al. Selection of cancer chemotherapy for a patient by anin vitro assay versus a clinician. JNCI 82:110–116; 1990.

    Google Scholar 

  51. Von Hoff, D. D.; Sandbach, J.; Osborne, C. K., et al. Potential and problems with growth of breast cancer in a human tumor cloning system. Breast Cancer Res. Treat. 1:141–148; 1981.

    Google Scholar 

  52. Von Hoff, D. D.; Sarosy, G.; Brown, T. D., et al. Rationale for and conduct of a phase I clinical trial with interferon alpha-2b plus doxorubicin. Semin. Oncol. 13:72–77; 1986.

    Google Scholar 

  53. Von Hoff, D. D., Weisenthal, L.In vitro methods to predict for patient response to chemotherapy. In: Garattini, S.; Goldin, A.; Hawkins, F., et al., eds. Advances in pharmacology and chemotherapy, vol. 12. New York: Academic Press; 1980:133–156.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Von Hoff, D.D., Marshall, M., Chacon, D. et al. Cloning of primary human tumor colony forming units in glass capillaries. Journal of Tissue Culture Methods 13, 125–131 (1991). https://doi.org/10.1007/BF01666143

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01666143

Key words

Navigation